{"transactions":[{"id":737609,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T21:00:15.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":106393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":106393,"derivative":{"exercise_price":0.96,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":106393},"source":{"system":"sec-edgar","filing":"0001222362-26-000013","document":"form4-06152026_050603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000013/form4-06152026_050603.xml","form_type":"4"}},{"id":741435,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T22:07:44.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":17335,"derivative":{"exercise_price":0.935,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17335},"source":{"system":"sec-edgar","filing":"0001222362-26-000010","document":"form4-06112026_100640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000010/form4-06112026_100640.xml","form_type":"4"}},{"id":741434,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T22:07:44.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":17550,"derivative":{"exercise_price":0.935,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17550},"source":{"system":"sec-edgar","filing":"0001222362-26-000010","document":"form4-06112026_100640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000010/form4-06112026_100640.xml","form_type":"4"}},{"id":741433,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T22:07:44.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":11675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":23600,"source":{"system":"sec-edgar","filing":"0001222362-26-000010","document":"form4-06112026_100640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000010/form4-06112026_100640.xml","form_type":"4"}},{"id":741432,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T22:07:44.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":11925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":11925,"source":{"system":"sec-edgar","filing":"0001222362-26-000010","document":"form4-06112026_100640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000010/form4-06112026_100640.xml","form_type":"4"}},{"id":749537,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001222362-26-000008","document":"wk-form4_1780606035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122236226000008/wk-form4_1780606035.xml","form_type":"4"}},{"id":749536,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:18.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001222362-26-000008","document":"wk-form4_1780606035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122236226000008/wk-form4_1780606035.xml","form_type":"4"}},{"id":749535,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:47:18.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117523,"source":{"system":"sec-edgar","filing":"0001222362-26-000008","document":"wk-form4_1780606035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122236226000008/wk-form4_1780606035.xml","form_type":"4"}},{"id":808693,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-14T12:08:56.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 5, 2025, the Reporting Person was granted 25,000 restricted stock units which vest in four equal installments on March 10, 2025, June 10, 2025, September 10 2025 and December 10, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 5, 2025, the Reporting Person was granted 25,000 restricted stock units which vest in four equal installments on March 10, 2025, June 10, 2025, September 10 2025 and December 10, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001222362-26-000006","document":"form4-04142026_120452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000006/form4-04142026_120452.xml","form_type":"4"}},{"id":808692,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-14T12:08:56.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001222362-26-000006","document":"form4-04142026_120452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000006/form4-04142026_120452.xml","form_type":"4"}},{"id":924718,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-02T13:43:47.000Z","date":"2026-01-30","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.04,"value":20800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.07. The reporting person undertakes to provide Elutia Inc. ( the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":118750,"source":{"system":"sec-edgar","filing":"0001222362-26-000004","document":"form4-02022026_010244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000004/form4-02022026_010244.xml","form_type":"4"}},{"id":927783,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-29T22:51:15.000Z","date":"2026-01-29","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.06,"value":15900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.10. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":98750,"source":{"system":"sec-edgar","filing":"0001222362-26-000002","document":"form4-01292026_100111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000002/form4-01292026_100111.xml","form_type":"4"}},{"id":927782,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-29T22:51:15.000Z","date":"2026-01-28","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.06,"value":15900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.10. The reporting person undertakes to provide Elutia Inc. ( the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":83750,"source":{"system":"sec-edgar","filing":"0001222362-26-000002","document":"form4-01292026_100111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236226000002/form4-01292026_100111.xml","form_type":"4"}},{"id":983352,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-02T22:00:06.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 20, 2023, the Reporting Person was granted 50,000 restricted stock units which vest in eight equal installments on March 1, 2024, June 1, 2024, September 1, 2024, December 1, 2024, March 1, 2025, June 1, 2025, September 1, 2025 and December 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 20, 2023, the Reporting Person was granted 50,000 restricted stock units which vest in eight equal installments on March 1, 2024, June 1, 2024, September 1, 2024, December 1, 2024, March 1, 2025, June 1, 2025, September 1, 2025 and December 1, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001222362-25-000009","document":"form4-12022025_051201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236225000009/form4-12022025_051201.xml","form_type":"4"}},{"id":983351,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-02T22:00:06.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":68750,"source":{"system":"sec-edgar","filing":"0001222362-25-000009","document":"form4-12022025_051201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236225000009/form4-12022025_051201.xml","form_type":"4"}},{"id":1019105,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-14T13:27:25.000Z","date":"2025-10-09","kind":"grant","planned":false,"acquired":true,"shares":171916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests annually in three equal installments of one-third each, on each of the first three anniversaries of the grant date,  such that the option shall be fully vested and exercisable on October 9, 2028."}],"balance_after":171916,"derivative":{"exercise_price":0.88,"expiration_date":"2035-10-09","underlying":"Class A Common Stock","underlying_shares":171916},"source":{"system":"sec-edgar","filing":"0001222362-25-000007","document":"form4-10142025_011021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222362/000122236225000007/form4-10142025_011021.xml","form_type":"4"}},{"id":1115736,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T20:24:16.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":4073,"price":10.61,"value":43214.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold on June 9, 2025 in multiple transactions at prices ranging from $10.47 to $10.61 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":86743,"source":{"system":"sec-edgar","filing":"0000805928-25-000082","document":"wk-form4_1749673449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000082/wk-form4_1749673449.xml","form_type":"4"}},{"id":1122896,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T01:30:20.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":32282,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001578563-25-000307","document":"wk-form4_1749087015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000307/wk-form4_1749087015.xml","form_type":"4"}},{"id":1122895,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T01:30:20.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":26493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":26493},"source":{"system":"sec-edgar","filing":"0001578563-25-000307","document":"wk-form4_1749087015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000307/wk-form4_1749087015.xml","form_type":"4"}},{"id":1122894,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-05T01:30:20.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":true,"shares":26493,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":85241,"source":{"system":"sec-edgar","filing":"0001578563-25-000307","document":"wk-form4_1749087015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000307/wk-form4_1749087015.xml","form_type":"4"}},{"id":1416935,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-09-05T01:11:56.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-24-000120","document":"wk-form4_1725497999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000120/wk-form4_1725497999.xml","form_type":"4"}},{"id":1416934,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T01:11:56.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on September 1,  2024."}],"balance_after":90816,"source":{"system":"sec-edgar","filing":"0000805928-24-000120","document":"wk-form4_1725497999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000120/wk-form4_1725497999.xml","form_type":"4"}},{"id":1480686,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-13T21:27:19.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":26493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":26493,"derivative":{"underlying":"Class A Common Stock","underlying_shares":26493},"source":{"system":"sec-edgar","filing":"0001578563-24-000288","document":"wk-form4_1718314032.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000288/wk-form4_1718314032.xml","form_type":"4"}},{"id":1483447,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-12T00:45:57.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":false,"shares":30400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 7, 2024."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":30400},"source":{"system":"sec-edgar","filing":"0001578563-24-000269","document":"wk-form4_1718153150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000269/wk-form4_1718153150.xml","form_type":"4"}},{"id":1483446,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-12T00:45:57.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":true,"shares":30400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58748,"source":{"system":"sec-edgar","filing":"0001578563-24-000269","document":"wk-form4_1718153150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856324000269/wk-form4_1718153150.xml","form_type":"4"}},{"id":1485707,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2024-06-10T22:13:46.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":18248,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0000805928-24-000093","document":"wk-form4_1718057618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000093/wk-form4_1718057618.xml","form_type":"4"}},{"id":1485706,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T22:13:46.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":10653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."}],"balance_after":78912,"source":{"system":"sec-edgar","filing":"0000805928-24-000093","document":"wk-form4_1718057618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000093/wk-form4_1718057618.xml","form_type":"4"}},{"id":1786356,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-09-07T10:24:41.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":11904,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-23-000108","document":"wf-form4_169408226866836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000108/wf-form4_169408226866836.xml","form_type":"4"}},{"id":1786355,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2023-09-07T10:24:41.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":20436,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0000805928-23-000108","document":"wf-form4_169408226866836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000108/wf-form4_169408226866836.xml","form_type":"4"}},{"id":1802507,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T20:12:03.000Z","date":"2023-08-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.11,"value":61100.0,"ownership":{"direct":true},"balance_after":68259,"source":{"system":"sec-edgar","filing":"0000805928-23-000099","document":"wf-form4_169238951009652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000099/wf-form4_169238951009652.xml","form_type":"4"}},{"id":1862270,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-08T23:32:08.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":30400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":30400,"derivative":{"underlying":"Class A Common Stock","underlying_shares":30400},"source":{"system":"sec-edgar","filing":"0001578563-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000041/primary_doc.xml","form_type":"4"}},{"id":1862269,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-08T23:32:08.000Z","date":"2023-06-06","kind":"exercise","planned":false,"acquired":false,"shares":16648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 6, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":16648},"source":{"system":"sec-edgar","filing":"0001578563-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000041/primary_doc.xml","form_type":"4"}},{"id":1862268,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-08T23:32:08.000Z","date":"2023-06-06","kind":"exercise","planned":false,"acquired":true,"shares":16648,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28348,"source":{"system":"sec-edgar","filing":"0001578563-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000041/primary_doc.xml","form_type":"4"}},{"id":1868347,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T22:52:06.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-23-000064","document":"wf-form4_168600551404884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000064/wf-form4_168600551404884.xml","form_type":"4"}},{"id":1868346,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:52:06.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on June 1, 2023."}],"balance_after":58259,"source":{"system":"sec-edgar","filing":"0000805928-23-000064","document":"wf-form4_168600551404884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000064/wf-form4_168600551404884.xml","form_type":"4"}},{"id":2224124,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-23T00:38:24.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":16648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":16648,"derivative":{"underlying":"Class A Common Stock","underlying_shares":16648},"source":{"system":"sec-edgar","filing":"0000899243-22-023637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322023637/doc4.xml","form_type":"4"}},{"id":2246230,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:09:01.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6459,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-22-000064","document":"wf-form4_165428692328229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000064/wf-form4_165428692328229.xml","form_type":"4"}},{"id":2246229,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2022-06-03T20:09:01.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":11811,"derivative":{"exercise_price":9.29,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":11811},"source":{"system":"sec-edgar","filing":"0000805928-22-000064","document":"wf-form4_165428692328229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000064/wf-form4_165428692328229.xml","form_type":"4"}},{"id":2246228,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:09:01.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-22-000064","document":"wf-form4_165428692328229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000064/wf-form4_165428692328229.xml","form_type":"4"}},{"id":2246227,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:09:01.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on June 1, 2022."}],"balance_after":51800,"source":{"system":"sec-edgar","filing":"0000805928-22-000064","document":"wf-form4_165428692328229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000064/wf-form4_165428692328229.xml","form_type":"4"}},{"id":2304463,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-06T01:12:01.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on April 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on April 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0000899243-22-013957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322013957/doc4.xml","form_type":"4"}},{"id":2304462,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-04-06T01:12:01.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":2700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."}],"balance_after":11700,"source":{"system":"sec-edgar","filing":"0000899243-22-013957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322013957/doc4.xml","form_type":"4"}},{"id":2394520,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-16T02:33:22.000Z","date":"2022-02-11","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested on February 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested on February 11, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-22-006552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006552/doc4.xml","form_type":"4"}},{"id":2394519,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-02-16T02:33:22.000Z","date":"2022-02-11","kind":"exercise","acquired":true,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0000899243-22-006552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006552/doc4.xml","form_type":"4"}},{"id":2680086,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2021-06-07T21:25:12.000Z","date":"2021-05-19","kind":"exercise","acquired":false,"shares":15000,"price":5.09,"value":76350.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016 (1 year from the option grant date) based upon a vesting schedule whereby 25% of the total shares vested at the end of each fiscal quarter."}],"balance_after":0,"derivative":{"exercise_price":5.09,"expiration_date":"2022-12-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000805928-21-000115","document":"wf-form4a_162310109457355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000115/wf-form4a_162310109457355.xml","form_type":"4/A","original_submission_date":"2021-05-21"}},{"id":2680085,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-07T21:25:12.000Z","date":"2021-05-19","kind":"exercise","acquired":false,"shares":25000,"price":3.8,"value":95000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Common Stock underlying the employee stock option became fully vested on August 26, 2017 (2 years from the option grant date) based upon a vesting schedule whereby 12.5% of total shares vested at the end of each fiscal quarter."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2022-08-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000805928-21-000115","document":"wf-form4a_162310109457355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000115/wf-form4a_162310109457355.xml","form_type":"4/A","original_submission_date":"2021-05-21"}},{"id":2680084,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T21:25:12.000Z","date":"2021-05-19","kind":"exercise","acquired":true,"shares":15000,"price":5.09,"value":76350.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person has elected to exercise and hold the shares at this time."}],"balance_after":42591,"source":{"system":"sec-edgar","filing":"0000805928-21-000115","document":"wf-form4a_162310109457355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000115/wf-form4a_162310109457355.xml","form_type":"4/A","original_submission_date":"2021-05-21"}},{"id":2680083,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T21:25:12.000Z","date":"2021-05-19","kind":"exercise","acquired":true,"shares":25000,"price":3.8,"value":95000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on May 21, 2021. The original Form 4 had the incorrect address for the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person has elected to exercise and hold the shares at this time."}],"balance_after":27591,"source":{"system":"sec-edgar","filing":"0000805928-21-000115","document":"wf-form4a_162310109457355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000115/wf-form4a_162310109457355.xml","form_type":"4/A","original_submission_date":"2021-05-21"}},{"id":2684906,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-03T21:12:49.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":3036,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-21-000108","document":"wf-form4_162275473035646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000108/wf-form4_162275473035646.xml","form_type":"4"}},{"id":2684905,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2021-06-03T21:12:49.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6030,"derivative":{"exercise_price":19.76,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0000805928-21-000108","document":"wf-form4_162275473035646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000108/wf-form4_162275473035646.xml","form_type":"4"}},{"id":2684904,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-03T21:12:49.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This reflects the number of restricted stock units that became vested as of June 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This reflects the number of restricted stock units that became vested as of June 1, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6173},"source":{"system":"sec-edgar","filing":"0000805928-21-000108","document":"wf-form4_162275473035646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000108/wf-form4_162275473035646.xml","form_type":"4"}},{"id":2684903,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:12:49.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48764,"source":{"system":"sec-edgar","filing":"0000805928-21-000108","document":"wf-form4_162275473035646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000108/wf-form4_162275473035646.xml","form_type":"4"}},{"id":2701935,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2021-05-21T20:21:33.000Z","date":"2021-05-19","kind":"exercise","acquired":false,"shares":15000,"price":5.09,"value":76350.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016 (1 year from the option grant date) based upon a vesting schedule whereby 25% of the total shares vested at the end of each fiscal quarter."}],"balance_after":0,"derivative":{"exercise_price":5.09,"expiration_date":"2022-12-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000805928-21-000096","document":"wf-form4_162162845853460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000096/wf-form4_162162845853460.xml","form_type":"4"}},{"id":2701934,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-21T20:21:33.000Z","date":"2021-05-19","kind":"exercise","acquired":false,"shares":25000,"price":3.8,"value":95000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Common Stock underlying the employee stock option became fully vested on August 26, 2017 (2 years from the option grant date) based upon a vesting schedule whereby 12.5% of total shares vested at the end of each fiscal quarter."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2022-08-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000805928-21-000096","document":"wf-form4_162162845853460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000096/wf-form4_162162845853460.xml","form_type":"4"}},{"id":2701933,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T20:21:33.000Z","date":"2021-05-19","kind":"exercise","acquired":true,"shares":15000,"price":5.09,"value":76350.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person has elected to exercise and hold the shares at this time."}],"balance_after":42591,"source":{"system":"sec-edgar","filing":"0000805928-21-000096","document":"wf-form4_162162845853460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000096/wf-form4_162162845853460.xml","form_type":"4"}},{"id":2701932,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T20:21:33.000Z","date":"2021-05-19","kind":"exercise","acquired":true,"shares":25000,"price":3.8,"value":95000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person has elected to exercise and hold the shares at this time."}],"balance_after":27591,"source":{"system":"sec-edgar","filing":"0000805928-21-000096","document":"wf-form4_162162845853460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000096/wf-form4_162162845853460.xml","form_type":"4"}},{"id":2757920,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-05T20:31:05.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on April 1, 2022 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on April 1, 2022 and have no expiration date."}],"balance_after":2700,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0000899243-21-014830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321014830/doc4.xml","form_type":"4"}},{"id":2859115,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-16T23:13:00.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on February 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on February 11, 2022."}],"balance_after":9000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-21-006749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321006749/doc4.xml","form_type":"4"}},{"id":3037044,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-08T21:37:22.000Z","date":"2020-09-03","kind":"grant","acquired":true,"shares":2591,"price":11.75,"value":30444.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of September 3, 2020."}],"balance_after":2591,"source":{"system":"sec-edgar","filing":"0001179110-20-009636","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020009636/edgar.xml","form_type":"4"}},{"id":3112553,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-12T20:23:30.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 2, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 2, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."}],"balance_after":6173,"derivative":{"underlying":"Common Stock","underlying_shares":6173},"source":{"system":"sec-edgar","filing":"0001179110-20-007284","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020007284/edgar.xml","form_type":"4/A","original_submission_date":"2020-06-03"}},{"id":3112552,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2020-06-12T20:23:30.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":12605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 2, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."}],"balance_after":12605,"derivative":{"exercise_price":9.72,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":12605},"source":{"system":"sec-edgar","filing":"0001179110-20-007284","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020007284/edgar.xml","form_type":"4/A","original_submission_date":"2020-06-03"}},{"id":3125665,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-03T21:46:47.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":4115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 2, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 2, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":4115,"derivative":{"underlying":"Common Stock","underlying_shares":4115},"source":{"system":"sec-edgar","filing":"0001179110-20-006938","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020006938/edgar.xml","form_type":"4"}},{"id":3125664,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2020-06-03T21:46:47.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":16807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 2, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":16807,"derivative":{"exercise_price":9.72,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":16807},"source":{"system":"sec-edgar","filing":"0001179110-20-006938","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020006938/edgar.xml","form_type":"4"}},{"id":3422525,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-09-05T21:09:33.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":2591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":2591,"derivative":{"underlying":"Common Stock","underlying_shares":2591},"source":{"system":"sec-edgar","filing":"0001179110-19-010125","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019010125/edgar.xml","form_type":"4"}},{"id":3422524,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2019-09-05T21:09:33.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":10710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":10710,"derivative":{"exercise_price":15.44,"expiration_date":"2029-09-03","underlying":"Common Stock","underlying_shares":10710},"source":{"system":"sec-edgar","filing":"0001179110-19-010125","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019010125/edgar.xml","form_type":"4"}},{"id":3566116,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T16:09:22.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":22692,"price":6.61,"value":149994.12,"ownership":{"direct":true},"balance_after":43200,"source":{"system":"sec-edgar","filing":"0001013606-19-000072","document":"wf-form4_155432214047185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000072/wf-form4_155432214047185.xml","form_type":"4"}},{"id":3710232,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T17:49:20.000Z","date":"2018-12-30","kind":"grant","acquired":true,"shares":120887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"100% of the time-based restricted stock unit award shall vest on December 30, 2019 and shall settle in shares of common stock."}],"balance_after":205089,"source":{"system":"sec-edgar","filing":"0001013606-19-000024","document":"wf-form4_154655574279125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000024/wf-form4_154655574279125.xml","form_type":"4"}},{"id":3906884,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2018-06-05T21:01:27.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":4780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Non-qualified stock option grant for service as Director on Company's Board of directors.  Options vest in equal installments every three months for the first nine months, with the final installment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019.  Number of shares pursuant to option are based on $120,000 valuation as of the grant date."}],"balance_after":4780,"derivative":{"exercise_price":49.65,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":4780},"source":{"system":"sec-edgar","filing":"0001179110-18-008096","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018008096/edgar.xml","form_type":"4"}},{"id":4023586,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T15:17:05.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":10.62,"value":53100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting in full on the earlier of June 13, 2018 and the date of the annual stockholder meeting following June 13, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-18-000027","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000027/primary_doc.xml","form_type":"4"}},{"id":4023585,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T15:17:05.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":5.74,"value":57400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in full on the earlier of June 14, 2017 and the date of the annual stockholder meeting following June 14, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":18.26,"expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001235802-18-000027","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000027/primary_doc.xml","form_type":"4"}},{"id":4023584,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T15:17:05.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":12.64,"value":189600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting in quarterly installments over 36 months commencing on December 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":11.36,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001235802-18-000027","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000027/primary_doc.xml","form_type":"4"}},{"id":4023583,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-03-01T15:17:05.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":17500,"price":24,"value":420000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-18-000027","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000027/primary_doc.xml","form_type":"4"}},{"id":4155443,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-21T20:31:00.000Z","date":"2017-11-20","kind":"sale","acquired":false,"shares":1150000,"price":19.74,"value":22701000.0,"ownership":{"direct":false,"nature":"By Essex Woodlands Fund IX, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares are owned directly by Essex Woodlands Fund IX, L.P., a limited partnership of which Essex Woodlands Fund IX-GP, L.P., is the general partner, and of which Essex Woodlands Fund IX, LLC is the general partner. The reporting person is an owner of a limited partnership interest in Essex Woodlands Fund IX, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":3371111,"source":{"system":"sec-edgar","filing":"0000899243-17-027155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000089924317027155/doc4.xml","form_type":"4"}},{"id":4282119,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T17:00:07.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the earlier to occur of June 13, 2018 and the date of the Company's annual meeting of stockholders immediately following June 13, 2017, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":5000,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-17-000084","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000084/primary_doc.xml","form_type":"4"}},{"id":4282118,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-14T17:00:07.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001235802-17-000084","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000084/primary_doc.xml","form_type":"4"}},{"id":4289038,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2017-06-08T17:39:24.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Non-qualified stock option grant for service as Director on Company's Board of directors.  Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting."}],"balance_after":15000,"derivative":{"exercise_price":14.85,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-17-008753","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017008753/edgar.xml","form_type":"4"}},{"id":4296596,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-02T12:21:04.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":22822,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":84202,"source":{"system":"sec-edgar","filing":"0001013606-17-000080","document":"wf-form4_149642044737275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000080/wf-form4_149642044737275.xml","form_type":"4"}},{"id":4308680,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-23T10:56:07.000Z","date":"2017-05-19","kind":"purchase","acquired":true,"shares":20000,"price":4.32,"value":86400.0,"ownership":{"direct":true},"balance_after":61380,"source":{"system":"sec-edgar","filing":"0001013606-17-000055","document":"wf-form4_149555135189697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000055/wf-form4_149555135189697.xml","form_type":"4"}},{"id":4509019,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2017-01-03T22:06:39.000Z","date":"2016-12-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Non-qualified stock option grant for service as Director on Company's Board of directors.  Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders."}],"balance_after":5000,"derivative":{"exercise_price":8.95,"expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001179110-17-000096","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017000096/edgar.xml","form_type":"4"}},{"id":4545647,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T10:27:10.000Z","date":"2016-11-18","kind":"purchase","acquired":true,"shares":13000,"price":7.69,"value":99970.0,"ownership":{"direct":true},"balance_after":41380,"source":{"system":"sec-edgar","filing":"0001013606-16-000321","document":"wf-form4_147982841828705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360616000321/wf-form4_147982841828705.xml","form_type":"4"}}]}